<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJGas</journal-id><journal-title-group><journal-title>Open Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="epub">2163-9450</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojgas.2024.145021</article-id><article-id pub-id-type="publisher-id">OJGas-133485</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Epidemiological and Paraclinical Aspects of &lt;i&gt;Helicobacter&lt;/i&gt; &lt;i&gt;pylori&lt;/i&gt; Infection among Hepatitis B Virus Carriers in the Republic of Congo
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jile</surname><given-names>Florient Mimiesse Monamou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nuptia</surname><given-names>Kanoha Elenga</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ngala</surname><given-names>Itoua Ngaporo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Clausina</surname><given-names>Ahoui Apendi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Marlyse</surname><given-names>Ngalessami Mouakosso</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Arnaud</surname><given-names>Mongo Onkouo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mauria</surname><given-names>Ibobi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rody</surname><given-names>St&amp;#233;phane Ngami</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mardoch&amp;#233;</surname><given-names>Motoula Latou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hostaud</surname><given-names>Atipo Ibara</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>C&amp;#233;line</surname><given-names>Sandra Adoua</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>D&amp;#233;by</surname><given-names>Gassaye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Blaise</surname><given-names>Ir&amp;#233;n&amp;#233;e Atipo Ibara</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Faculty of Health Sciences, Marien Ngouabi University, Brazzaville, The Republic of Congo</addr-line></aff><aff id="aff1"><addr-line>Department of Gastroenterology and Internal Medicine, Brazzaville University Hospital, Brazzaville, The Republic of Congo</addr-line></aff><pub-date pub-type="epub"><day>11</day><month>05</month><year>2024</year></pub-date><volume>14</volume><issue>05</issue><fpage>184</fpage><lpage>191</lpage><history><date date-type="received"><day>21,</day>	<month>March</month>	<year>2024</year></date><date date-type="rev-recd"><day>26,</day>	<month>May</month>	<year>2024</year>	</date><date date-type="accepted"><day>29,</day>	<month>May</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  &lt;b&gt;Objective:&lt;/b&gt;&lt;b&gt; &lt;/b&gt;Describe the epidemiological and paraclinical aspects of HP infection in hepatitis B virus carriers. &lt;b&gt;Population&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;and&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;Method&lt;/b&gt;&lt;b&gt;:&lt;/b&gt;&lt;b&gt; &lt;/b&gt;This was a descriptive cross-sectional study running from January 1 to August 30, 2019, a period of 8 months. It took place in the Hospital Centers of the two major cities of Congo (Brazzaville and Pointe-Noire). The target population of our study consists of patients carrying HBV under antiviral treatment or not. Patients aged at least 18 years and consenting with a biological and morphological assessment were included. We did not include in our study patients taking or having taken antibiotics and/or PPIs less than 4 weeks ago. We excluded all patients who did not deposit fresh stools and those in whom stool extraction could not be done manually. The variables studied covered sociodemographic, clinical and paraclinical aspects. Data entry was done using Excel 8.0 software. Statistical analysis was carried out with SPSS 20.0 software. &lt;b&gt;Results:&lt;/b&gt;&lt;b&gt; &lt;/b&gt;During our study, we included 169 patients. The frequency of HPAG in the stools of HBV carriers in our study population was 63.9% (n = 109). Male patients represented 69% (n = 75) and female patients represented 31% (n = 34). The average age of the patients is 43.92 &amp;#177; 13.51 years with extremes of 18 years and 80 years. Concerning profession, unemployed patients and those working in the private sector were the most represented in respectively 28.4% (n = 31) and 22.9% (n = 25) without statistical link. Households comprising between 4 - 10 people and the use of public latrines were the risk factors most represented in respectively 69% (n = 75) and 88% (n = 96) without statistical link. Clinically, hepatomegaly and signs of portal hypertension were most represented in 53% (n = 58) and 47% (n = 51). Biologically, HBV DNA was detectable in 60.5% of cases (n = 66).
 
</p></abstract><kwd-group><kwd>&lt;i&gt;Helicobacter&lt;/i&gt; &lt;i&gt;pylori&lt;/i&gt;</kwd><kwd> Hepatitis B Virus</kwd><kwd> Congo</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Hepatitis B virus (HBV) and Helicobacter pylori (HP) infections each constitute a major public health problem worldwide [<xref ref-type="bibr" rid="scirp.133485-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.133485-ref2">2</xref>] .</p><p>According to the World Health Organization (WHO), the global prevalence of HBV in 2015 was estimated at 10.5% [<xref ref-type="bibr" rid="scirp.133485-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.133485-ref3">3</xref>] . Sub-Saharan Africa is located in an area of high endemicity of HBV infection. The prevalences are generally greater than or equal to 8% [<xref ref-type="bibr" rid="scirp.133485-ref4">4</xref>] . In 2015, Atipo Ibara et al. reported a frequency of 9.9% in a study on the seroprevalence of HBV among blood donors in Congo [<xref ref-type="bibr" rid="scirp.133485-ref5">5</xref>] . A recent study carried out by Itoua Ngaporo Ngala et al. in 2018 reported a frequency HP of 79.8% among adults in Brazzaville [<xref ref-type="bibr" rid="scirp.133485-ref6">6</xref>] .</p><p>A primary event in the natural history of viral hepatitis B is the development of cirrhosis and hepatocellular carcinoma (HCC) are largely responsible for the high morbidity and mortality of this condition [<xref ref-type="bibr" rid="scirp.133485-ref7">7</xref>] . The occurrence of these complications involves factors linked to the virus, the environment and the terrain. Apart from age and gender, comorbidities play an important role.</p><p>The association between HP infection and chronic viral hepatitis B has been the subject of several studies in recent decades. Abu Al-Soud et al. reported that the presence of hpDNA in HBV-contaminated samples is associated with a high risk of developing HCC [<xref ref-type="bibr" rid="scirp.133485-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.133485-ref9">9</xref>] .</p><p>A Chinese study carried out on patients with liver disease at different stages, showed a high rate of HP infection [<xref ref-type="bibr" rid="scirp.133485-ref10">10</xref>] .</p><p>Ponzetto et al. in the 2000s found a prevalence of 89% versus 59% [<xref ref-type="bibr" rid="scirp.133485-ref11">11</xref>] .</p><p>In Congo, no study has been conducted on HP-HBV co-infection. The objective of this work was to describe the epidemiological and paraclinical aspects of HP infection in HBV carriers.</p></sec><sec id="s2"><title>2. Patients and Method</title><p>This was a descriptive cross-sectional study ranging from January 1 to August 30, 2019, a period of 8 months. It took place in the Hospital Centers of the two major cities of Congo (Brazzaville and Pointe-Noire). The target population of our study consists of patients carrying HBV under antiviral treatment or not. Patients aged at least 18 years and consenting with a biological and morphological assessment were included. We did not include in our study patients taking or having taken antibiotics and/or PPIs less than 4 weeks ago. We excluded all patients who did not deposit fresh stools and those in whom stool extraction could not be done manually. Data collection was carried out in the different locations of the study. Data collection took place in two phases. Data collection using a pre-established survey form followed by stool sampling and analysis. This sampling consisted of searching for the HP antigen in the patients’ fresh stools using a ‘CerTest Hp<sup>&#174;</sup>’ rapid detection kit. The variables studied covered sociodemographic, clinical and paraclinical aspects. Data entry was done using Excel 8.0 software. Statistical analysis was carried out with SPSS 20.0 software. The quantitative variables were presented as mean and/or standard deviation and the qualitative ordinal and nominal variables as number and percentage. Comparative tests were carried out with the Pearson chi2 test or the Fischer test. The test was considered significant when p ≤ 0.05.</p></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Sociodemographic Aspects</title><p>During our study, we included 169 patients. The frequency of HPAG in the stools of HBV carriers in our study population was 63.9% (n = 109).</p><p>Male patients represented 69% (n = 75) and female patients represented 31% (n = 34). The average age of the patients is 43.92 &#177; 13.51 years with the extremes of 18 years and 80 years. HP infection predominated in the age group over 40, at a rate of 64.50%. Sociodemographic aspects are represented in <xref ref-type="table" rid="table1">Table 1</xref>.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Socio-demographic factors of HP+ patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  colspan="2"  >VHB-HP+ (N = 109)</th><th align="center" valign="middle"  rowspan="2"  >p</th></tr></thead><tr><td align="center" valign="middle" >N</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >Sex</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="3"  >0.396</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >69</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >34</td></tr><tr><td align="center" valign="middle" >Age groups (year)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="5"  >0.894</td></tr><tr><td align="center" valign="middle" >&lt;20</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2.7</td></tr><tr><td align="center" valign="middle" >20 - 30</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >31 - 40</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >22</td></tr><tr><td align="center" valign="middle" >≥40</td><td align="center" valign="middle" >71</td><td align="center" valign="middle" >66</td></tr><tr><td align="center" valign="middle" >Occupations</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="7"  >0.05</td></tr><tr><td align="center" valign="middle" >Public sector</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >19.2</td></tr><tr><td align="center" valign="middle" >Private sector</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >22.9</td></tr><tr><td align="center" valign="middle" >Informal private sector</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >13.7</td></tr><tr><td align="center" valign="middle" >Retirement</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2.7</td></tr><tr><td align="center" valign="middle" >Student</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >12.8</td></tr><tr><td align="center" valign="middle" >Unemployed</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >28.4</td></tr></tbody></table></table-wrap></sec><sec id="s3_2"><title>3.2. Transmission Risk Factors</title><p>Households comprising between 4 - 10 people and the use of public latrines were the risk factors most represented in 69% (n = 75) and 88% (n = 96), respectively. The distribution of transmission risk factors is shown in <xref ref-type="table" rid="table2">Table 2</xref>.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Transmission risk factors among HP-HBV co-infected</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  colspan="2"  >HP-VHB (N = 109)</th><th align="center" valign="middle"  rowspan="2"  >p</th></tr></thead><tr><td align="center" valign="middle" >N</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >Type of latrine</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="4"  >0.668</td></tr><tr><td align="center" valign="middle" >Public</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >96</td><td align="center" valign="middle" >88</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >12</td></tr><tr><td align="center" valign="middle" >Private</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="3"  >0.015</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >79</td><td align="center" valign="middle" >72</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >27.5</td></tr><tr><td align="center" valign="middle" >Family number</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="4"  >0.723</td></tr><tr><td align="center" valign="middle" >0 - 1</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >11.9</td></tr><tr><td align="center" valign="middle" >2 - 3</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >19.2</td></tr><tr><td align="center" valign="middle" >4 - 10</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >68.8</td></tr><tr><td align="center" valign="middle" >Water sources</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="13"  >0.953</td></tr><tr><td align="center" valign="middle" >Tap water</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >95</td><td align="center" valign="middle" >87</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >13</td></tr><tr><td align="center" valign="middle" >Mineral water</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >74</td><td align="center" valign="middle" >68</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >32</td></tr><tr><td align="center" valign="middle" >Well water</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >106</td><td align="center" valign="middle" >97</td></tr><tr><td align="center" valign="middle" >Spring water</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >108</td><td align="center" valign="middle" >99</td></tr><tr><td align="center" valign="middle" >Water borehole</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="6"  >0.668</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >8</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >92</td></tr><tr><td align="center" valign="middle" >Hand washing</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >47</td><td align="center" valign="middle" >43</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >57</td></tr></tbody></table></table-wrap></sec><sec id="s3_3"><title>3.3 Clinical and Biological Signs</title><p>During our study, half of the patients had hepatomegaly (<xref ref-type="table" rid="table3">Table 3</xref>). Biologically, the viral load of the hepatitis virus was detectable in 60.6% of cases (n = 66). <xref ref-type="table" rid="table4">Table 4</xref> shows the distribution of patients according to biological signs</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Clinical signs of HP-HBV co-infected patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  colspan="2"  >VHB-HP+ (N = 109)</th><th align="center" valign="middle"  rowspan="2"  >p</th></tr></thead><tr><td align="center" valign="middle" >N</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >Hepatomegaly</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="3"  >0.0008</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >53.2</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >46.8</td></tr><tr><td align="center" valign="middle" >Portal hypertension</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="3"  >0.894</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >19.2</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >81</td><td align="center" valign="middle" >20.8</td></tr><tr><td align="center" valign="middle" >Hepatocellular insufficiency</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="3"  >0.523</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >9.1</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >99</td><td align="center" valign="middle" >89.9</td></tr><tr><td align="center" valign="middle" >Hematemesis and melena</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="3"  >0.603</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >8.2</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >90.8</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Biological signs of HP-HBV co-infected patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  colspan="2"  >VHB-HP+ (N = 109)</th><th align="center" valign="middle"  rowspan="2"  >p</th></tr></thead><tr><td align="center" valign="middle" >N</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >ADN VHB (Copies/mL)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="3"  >0.008</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >60.6</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >39.4</td></tr><tr><td align="center" valign="middle" >AFP (ng/mL)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="3"  >0.894</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >18.3</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >80</td><td align="center" valign="middle" >81.7</td></tr><tr><td align="center" valign="middle" >Liver fibrosis (fibroscan)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="3"  >0.523</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >39.4</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >60.6</td></tr><tr><td align="center" valign="middle" >Thrombocytopenia</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="3"  >0.603</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >18.4</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >89</td><td align="center" valign="middle" >81.6</td></tr></tbody></table></table-wrap></sec></sec><sec id="s4"><title>4. Discussion</title><p>The frequency of HP infection was 63.9% among chronic HBV carriers. Our results are superimposable to data from the literature. Indeed, work carried out in China by Hao Q et al. in 2017 as well as Li BS et al. in 2011 found a prevalence of 63.9% and 63.82% respectively [<xref ref-type="bibr" rid="scirp.133485-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.133485-ref13">13</xref>] . In Egypt, Amal AM et al. reported a prevalence of 60% in 2018 [<xref ref-type="bibr" rid="scirp.133485-ref14">14</xref>] . A study carried out in 2019 in Benin reported a frequency of 57.9% [<xref ref-type="bibr" rid="scirp.133485-ref15">15</xref>] . The similarity of the results observed in these studies could be explained by the fact that the sampling method used is identical and that the population of HBV carriers is predominantly male. On the other hand, some authors have reported frequencies below ours. This is Wang MY et al. in 2011 in China who found a prevalence of 38.67% [<xref ref-type="bibr" rid="scirp.133485-ref16">16</xref>] . This difference could be explained by the fact that the patients included in their study were asymptomatic carriers of HBV and probably have unevolved chronic hepatitis B with a relatively uncollapsed immune system.</p><p>The average age in this study was 43.92 &#177; 13.51 years with extremes of 18 and 80 years. There is no statistically significant difference between different age groups and HP infection in HBV carriers. But HP infection predominated in the age group over 40, at a rate of 64.50%. This average is similar to that reported by Wang MY et al. in China in 2011 of 43 years, as well as S&#233;honou J et al. in Cotonou (Benin) which was 42.3 &#177; 11.6 years [<xref ref-type="bibr" rid="scirp.133485-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.133485-ref16">16</xref>] .</p><p>In our study, the average number living under the same roof is 4.33 &#177; 2.32 people per household with no statistically significant link with HP infection. This result is higher than that of the study carried out by the EDSC-II which reports an average of 4.3. This result could be explained by the fact that large households are common in our countries [<xref ref-type="bibr" rid="scirp.133485-ref16">16</xref>] .</p><p>These results are contrary to those reported by Ji SW et al. in 2008 in China [<xref ref-type="bibr" rid="scirp.133485-ref9">9</xref>] . This discrepancy could be explained by the precarious conditions that we find in our countries, thus promoting promiscuity in households.</p><p>In our study, the use of public latrines was the most frequent in 88% of cases.</p><p>These results are similar to those of Itoua Ngaporo et al. in Brazzaville in 2018 as well as Aguenom et al. in Benin in 2005 who found a significant link between the type of latrine and HP infection with p = 0.016 [<xref ref-type="bibr" rid="scirp.133485-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.133485-ref17">17</xref>] . These similarities could be explained by the poor hygienic conditions of public latrines. Additionally, HP infection is known as dirty hands disease. After using public latrines, hand washing is not systematic.</p><p>The frequency of hepatomegaly in this population is 43.8%. This frequency is higher in patients carrying the hepatitis B virus. The existence of the large liver could be explained by the fact that half of the population was at the F4 fibrosis stage.</p><p>Our study noted a link between HBV viral load levels and HP infection. In Benin, S&#233;honou J et al. in 2018 as well as in China, Wang MY et al. in 2013 and Ji et al. in 2008 reported that there was no statistically significant link between HP infection and HBV DNA [<xref ref-type="bibr" rid="scirp.133485-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.133485-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.133485-ref16">16</xref>] .</p><p>On the other hand, Huang J et al. in 2017 and Xi et al. in 2015 reported that the rate of HP infection in patients with an HBV viral load greater than 103 copies/mL was significantly higher than in subjects with HBV viral load less than 103 copies/mL [<xref ref-type="bibr" rid="scirp.133485-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.133485-ref18">18</xref>] . Huang J et al. had suggested that HBV replication could increase the infection rate of Hp.</p></sec><sec id="s5"><title>5. Conclusion</title><p>This study highlighted a high frequency of Helicobacter pylori infection in chronic HBV carriers. The use of public latrines has been identified as a factor associated with co-infection.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Mimiesse Monamou, J.F., Kanoha Elenga, N., Itoua Ngaporo, N., Ahoui Apendi, C., Ngalessami Mouakosso, M., Mongo Onkouo, A., Ibobi, M., Ngami, R.S., Motoula Latou, M., Atipo Ibara, H., Adoua, C.S., Gassaye, D. and Atipo Ibara, B.I. (2024) Epidemiological and Paraclinical Aspects of Helicobacter pylori Infection among Hepatitis B Virus Carriers in the Republic of Congo. Open Journal of Gastroenterology, 14, 184-191. https://doi.org/10.4236/ojgas.2024.145021</p></sec></body><back><ref-list><title>References</title><ref id="scirp.133485-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organisation (2019) Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. World Health Organisation Guidelines. 10-12. </mixed-citation></ref><ref id="scirp.133485-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">James, K.Y., Hooi, Wan, Y.L., &lt;i&gt;et&lt;/i&gt; &lt;i&gt;al&lt;/i&gt;. (2017) Global Prevalence of &lt;i&gt;Helicobacter&lt;/i&gt; &lt;i&gt;pylori&lt;/i&gt; Infection: Systematic Review and Meta-Analysis. &lt;i&gt;Gastroenterology&lt;/i&gt;, 153, 420-429. &lt;br&gt;https://doi.org/10.1053/j.gastro.2017.04.022</mixed-citation></ref><ref id="scirp.133485-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2017) Weekly Epidemiological Record. &lt;i&gt;WER&lt;/i&gt;, 27, 369-392.</mixed-citation></ref><ref id="scirp.133485-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Kramvis, A. and Kew, M.C. (2007) Epidemiology of Hepatitis B Virus in Africa, Its Genotypes and Clinical Associations of Genotypes. &lt;i&gt;Hepatology&lt;/i&gt; &lt;i&gt;Research&lt;/i&gt;, 37, 9-19. &lt;br&gt;https://doi.org/10.1111/j.1872-034X.2007.00098.x</mixed-citation></ref><ref id="scirp.133485-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Atipo-Ibara, B.I., Itoua-Ngaporo, N.A., Dzia-Lepfoundzou, A., &lt;i&gt;et&lt;/i&gt; &lt;i&gt;al&lt;/i&gt;. (2015) Virus de l&amp;#8217;h&amp;#233;patite B au Congo (Brazzaville): S&amp;#233;ropr&amp;#233;valence et diversit&amp;#233; g&amp;#233;n&amp;#233;tique chez les donneurs de sang en zones hyper end&amp;#233;miques. &lt;i&gt;African&lt;/i&gt; &lt;i&gt;Journal&lt;/i&gt; &lt;i&gt;of&lt;/i&gt; &lt;i&gt;Gastroenterology&lt;/i&gt; &lt;i&gt;and&lt;/i&gt; &lt;i&gt;Hepatology&lt;/i&gt;, 9, 127-131. &lt;br&gt;https://doi.org/10.1007/s12157-015-0607-7</mixed-citation></ref><ref id="scirp.133485-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Itoua-Ngaporo, N.A., Mimiesse Monamou, J.F., Ahoui Apendi, C., &lt;i&gt;et&lt;/i&gt; &lt;i&gt;al&lt;/i&gt;. (2018) Epidemiological, Clinical and Endoscopic Profile of &lt;i&gt;Helicobacter&lt;/i&gt; &lt;i&gt;pylori&lt;/i&gt; Infection in Two Digestive Endoscopy Centers in Brazzaville. &lt;i&gt;Gastroenterology&lt;/i&gt;, &lt;i&gt;Hepatology&lt;/i&gt; &lt;i&gt;&amp;&lt;/i&gt; &lt;i&gt;Digestive&lt;/i&gt; &lt;i&gt;Disorders&lt;/i&gt;, 1, 1-5. &lt;br&gt;https://doi.org/10.33425/2639-9334.1025</mixed-citation></ref><ref id="scirp.133485-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Roche, B., Samuel, D., Pawlotsky, J.M., Dhumeaux, D., &lt;i&gt;et&lt;/i&gt; &lt;i&gt;al&lt;/i&gt;. (2009) Histoire naturelle de l&amp;#8217;infection par le virus de l&amp;#8217;h&amp;#233;patite B. H&amp;#233;patite B. 2 &amp;#233;d. &lt;i&gt;S&amp;#232;vres&lt;/i&gt; &lt;i&gt;Cedex&lt;/i&gt; (&lt;i&gt;France&lt;/i&gt;), 6, 95-111. &lt;br&gt;https://doi.org/10.1051/978-2-84254-223-8.c009</mixed-citation></ref><ref id="scirp.133485-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Abu Al-Soud, W., Sterram, U., Ljungh, A., &lt;i&gt;et&lt;/i&gt; &lt;i&gt;al&lt;/i&gt;. (2008) DNA of Helicobacter spp and Common Gut Bacteria in Primary Liver Carcinoma. &lt;i&gt;Digestive&lt;/i&gt; &lt;i&gt;and&lt;/i&gt; &lt;i&gt;Liver&lt;/i&gt; &lt;i&gt;Di&lt;/i&gt;&lt;i&gt;s&lt;/i&gt;&lt;i&gt;ease&lt;/i&gt;, 40, 126-131. &lt;br&gt;https://doi.org/10.1016/j.dld.2007.09.011</mixed-citation></ref><ref id="scirp.133485-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Amal, A.M., Amal, A.E., &lt;i&gt;et&lt;/i&gt; &lt;i&gt;al&lt;/i&gt;. (2018) Association between Severity of Liver Disease, Frequency of &lt;i&gt;H&amp;#233;licobacter&lt;/i&gt; &lt;i&gt;pylori&lt;/i&gt; Infection, and Degree of Gastric Lesion in Egyptian Patients with Hepatitis B Virus Infection. &lt;i&gt;American&lt;/i&gt; &lt;i&gt;Journal&lt;/i&gt; &lt;i&gt;of&lt;/i&gt; &lt;i&gt;Tropical&lt;/i&gt; &lt;i&gt;Med&lt;/i&gt;&lt;i&gt;i&lt;/i&gt;&lt;i&gt;cine&lt;/i&gt; &lt;i&gt;and&lt;/i&gt; &lt;i&gt;Hygiene&lt;/i&gt;, 98, 221-226. &lt;br&gt;https://doi.org/10.4269/ajtmh.17-0291</mixed-citation></ref><ref id="scirp.133485-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Wang, D.Z., Chen, W., Yang, S., &lt;i&gt;et&lt;/i&gt; &lt;i&gt;al&lt;/i&gt;. (2015) &lt;i&gt;Helicobacter&lt;/i&gt; &lt;i&gt;pylori&lt;/i&gt; Infection in Chinese Patients with Atrial Fibrillation. &lt;i&gt;Clinical&lt;/i&gt; &lt;i&gt;Interventions&lt;/i&gt; &lt;i&gt;in&lt;/i&gt; &lt;i&gt;Aging&lt;/i&gt;, 10, 813-819. &lt;br&gt;https://doi.org/10.2147/CIA.S72724</mixed-citation></ref><ref id="scirp.133485-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Ponzetto, A., Pellicano, R., Leone, N., &lt;i&gt;et&lt;/i&gt; &lt;i&gt;al&lt;/i&gt;. (2000) &lt;i&gt;Helicobacter&lt;/i&gt; &lt;i&gt;pylori&lt;/i&gt; Seroprevalence in Cirrhotic Patients with Hepatitis B Virus Infection. &lt;i&gt;The&lt;/i&gt; &lt;i&gt;Netherlands&lt;/i&gt; &lt;i&gt;Jou&lt;/i&gt;&lt;i&gt;r&lt;/i&gt;&lt;i&gt;nal&lt;/i&gt; &lt;i&gt;of&lt;/i&gt; &lt;i&gt;Medicine&lt;/i&gt;, 56, 206-210. &lt;br&gt;https://doi.org/10.1016/S0300-2977(00)00033-4</mixed-citation></ref><ref id="scirp.133485-ref12"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hao</surname><given-names> H.Q. </given-names></name>,<etal>et al</etal>. (<year>2015</year>)<article-title>The Research of HBV Related Liver Disease and &lt;i&gt;Helicobacter&lt;/i&gt; &lt;i&gt;p&lt;/i&gt;&lt;i&gt;y&lt;/i&gt;&lt;i&gt;lori&lt;/i&gt; Infection</article-title><source> &lt;i&gt;Public&lt;/i&gt; &lt;i&gt;Medical&lt;/i&gt; &lt;i&gt;Forum&lt;/i&gt; &lt;i&gt;Magazine&lt;/i&gt;</source><volume> 19</volume>,<fpage> 2921</fpage>-<lpage>2922</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.133485-ref13"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names> B.S. </given-names></name>,<etal>et al</etal>. (<year>2011</year>)<article-title>The Association between &lt;i&gt;Helicobacter&lt;/i&gt; &lt;i&gt;pylori&lt;/i&gt; Infection and HBV DNA Loads in Patients with Chronic Hepatitis B</article-title><source> &lt;i&gt;China&lt;/i&gt; &lt;i&gt;Practice&lt;/i&gt; &lt;i&gt;Medicine&lt;/i&gt;</source><volume> 10</volume>,<fpage> 2</fpage>-<lpage>3</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.133485-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Minist&amp;#232;re du Plan, de l&amp;#8217;Am&amp;#233;nagement, du Territoire, de l&amp;#8217;Int&amp;#233;gration Economique et du NEPAD, Centre National de la Statistique et des Etudes Economiques (2012) Enqu&amp;#234;te D&amp;#233;mographique et de Sant&amp;#233; du Congo (EDSC-II).</mixed-citation></ref><ref id="scirp.133485-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">S&amp;#233;honou, J., Kpossou, A.R., Kanvi, J.P., &lt;i&gt;et&lt;/i&gt; &lt;i&gt;al&lt;/i&gt;. (2019) &lt;i&gt;Helicobacter&lt;/i&gt; &lt;i&gt;pylori&lt;/i&gt; Infection in Hepatitis B Virus Carriers in Cotonou: Epidemiology and Sociodemographic Factors Associated with the Coinfection. &lt;i&gt;Gastroenterology&lt;/i&gt; &lt;i&gt;&amp;&lt;/i&gt; &lt;i&gt;Hepatology&lt;/i&gt;: &lt;i&gt;Open&lt;/i&gt; &lt;i&gt;Access&lt;/i&gt;, 10, 14-17. &lt;br&gt;https://doi.org/10.15406/ghoa.2019.10.00350</mixed-citation></ref><ref id="scirp.133485-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Wang, M.Y., Yue, J.Y., Zhang, Y.X., &lt;i&gt;et&lt;/i&gt; &lt;i&gt;al&lt;/i&gt;. (2011) &lt;i&gt;Helicobacter&lt;/i&gt; &lt;i&gt;pylori&lt;/i&gt; Infection in Asymptomatic HBV Carriers, Alcohol Users and Normal Adult Population in Shandong Province, China. &lt;i&gt;Clinics&lt;/i&gt; &lt;i&gt;and&lt;/i&gt; &lt;i&gt;Research&lt;/i&gt; &lt;i&gt;in&lt;/i&gt; &lt;i&gt;Hepatology&lt;/i&gt; &lt;i&gt;and&lt;/i&gt; &lt;i&gt;Gastroenterology&lt;/i&gt;, 3, 560-562. &lt;br&gt;https://doi.org/10.1016/j.clinre.2010.12.014</mixed-citation></ref><ref id="scirp.133485-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Ji, S.W., Wang, J.B. and Zhang, Y.G. (2008) The &lt;i&gt;Helicobacter&lt;/i&gt; &lt;i&gt;pylori&lt;/i&gt; Infection in Patients with Chronic Hepatitis B and the Relative Factor Analysis. &lt;i&gt;Liver&lt;/i&gt;, 20, 5-7. &lt;br&gt;https://doi.org/10.11569/wcjd.v16.i5.535</mixed-citation></ref><ref id="scirp.133485-ref18"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xi</surname><given-names> J.D. </given-names></name>,<etal>et al</etal>. (<year>2015</year>)<article-title>The &lt;i&gt;Helicobacter&lt;/i&gt; &lt;i&gt;pylori&lt;/i&gt; Infection in Patients with Chronic Hepatitis B, and/or Cirrhosis, Hepatocellular Carcinoma</article-title><source> &lt;i&gt;Hebei&lt;/i&gt; &lt;i&gt;Medicine&lt;/i&gt;</source><volume> 21</volume>,<fpage> 42</fpage>-<lpage>45</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref></ref-list></back></article>